Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
European Journal of Cancer2020Vol. 130, pp. 182–192
Citations Over TimeTop 10% of 2020 papers
Jianliang Yang, Lihou Dong, Sheng Yang, Xiaohong Han, Ying Han, Shiyu Jiang, Jiarui Yao, Zhishang Zhang, Shuxiang Zhang, Peng Liu, Yan Qin, Hai Wu, Hui Feng, Sheng Yao, Yan Sun, Haifeng Song, Yuankai Shi
Related Papers
- → Sensitivity and specificity of dosing alerts for dosing errors among hospitalized pediatric patients(2014)29 cited
- → Efficacy of nivolumab four-weekly dosing schedule based on body weight(2019)10 cited
- → Approaches to maintenance dosing during oral immunotherapy(2022)2 cited
- → The Impact of Role of Pharmacists in Renal Dosage Adjustment Program on Renal Drug Dosing Errors: A Quasi-Experimental Study(2021)1 cited
- → Pharmacokinetics‐Based Dosing Strategies for Therapeutic Proteins in Inflammatory Bowel Disease(2019)1 cited